Cited by 314Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement DisordersAlzheimer's disease research and treatments

The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.

Progressive Supranuclear Palsy: Pathology and Genetics

Open access

Dickson, Dennis W., Rademakers, Rosa, Hutton, Michael L.·2007·Brain Pathology

DOI 10.1111/j.1750-3639.2007.00054.xPMC PMC8095545

Open this paper in CoChat — free account

Abstract

Progressive supranuclear palsy (PSP) is an atypical Parkinsonian disorder associated with progressive axial rigidity, vertical gaze palsy, dysarthria and dysphagia. Neuropathologically, the subthalamic nucleus and brainstem, especially the midbrain tectum and the superior cerebellar peduncle, show atrophy. The substantia nigra shows loss of pigment corresponding to nigrostriatal dopaminergic degeneration. Microscopic findings include neuronal loss, gliosis and neurofibrillary tangles in basal ganglia, diencephalon and brainstem. Characteristic tau pathology is also found in glia. The major genetic risk factor for sporadic PSP is a common variant in the gene encoding microtubule‐associated protein tau (MAPT) and recent studies have suggested that this may result in the altered expression of specific tau protein isoforms. Imaging studies suggest that there may be sensitive and specific means to differentiate PSP from other parkinsonian disorders, but identification of a diagnostic biomarker is still elusive.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1111/j.1750-3639.2007.00054.x

Cites

99 of 99 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Self-citation
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Zimprich, A. A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M. J., Lincoln, S., Kachergus, J. M., Hulihan, M., Uitti, R. J., Calne, D. B., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.005 · Cited by 3,087
Self-citation
Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease
Paisán‐Ruiz, C., Jain, S., Evans, E. W., Gilks, W. P., Simón, J., van der Brug, M., de Munaín, A. L., Aparicio, S. F., Gil, A. M., Khan, N. L., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.10.023 · Cited by 2,453
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
Baker, M., Mackenzie, I. R., Pickering-Brown, S. M., Gass, J., Rademakers, R., Lindholm, C., Snowden, J., Adamson, J., Sadovnick, A. D., Rollinson, S., et al. (2006) · Nature · doi:10.1038/nature05016 · Cited by 2,058
Self-citation
Progressive Supranuclear Palsy
Steele, J. C. (1964) · Archives of Neurology · doi:10.1001/archneur.1964.00460160003001 · Cited by 1,930
Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21
Cruts, M., Gijselinck, I., van der Zee, J., Engelborghs, S., Wils, H., Pirici, D., Rademakers, R., Vandenberghe, R., Dermaut, B., Martin, J.-J., et al. (2006) · Nature · doi:10.1038/nature05017 · Cited by 1,512
Self-citation
Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., & Ghetti, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7737 · Cited by 1,474
Tau is a candidate gene for chromosome 17 frontotemporal dementia
Poorkaj, P., Bird, T. D., Wijsman, E., Nemens, E., Garruto, R. M., Anderson, L., Andreadis, A., Wiederholt, W. C., Raskind, M., & Schellenberg, G. D. (1998) · Annals of Neurology · doi:10.1002/ana.410430617 · Cited by 1,374
A common inversion under selection in Europeans
Stefánsson, H., Helgason, A., Þorleifsson, G., Steinthórsdóttir, V., Másson, G., Barnard, J., Baker, A., Jónasdóttir, Á., Ingason, A., Gudnadottir, V. G., et al. (2005) · Nature Genetics · doi:10.1038/ng1508 · Cited by 847

Show all 99 references

Sorted by citations

Items 201–300 of 313

The association of vagal atrophy with parameters of autonomic function in multiple system atrophy and progressive supranuclear palsy
Kleinz, T., Scholz, L., Huckemann, S., Rohmann, R., Kuhn, E. M., Averdunk, P., Kools, S., Hilker, L., Bieber, A., Müller, K., et al. (2024) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864241267300 · Cited by 3
The Pattern of Lesions During the Transition to the Symptomatic Phase and in Fully Developed Alzheimer’s Disease
Braak, H., & Tredici, K. D. (2014) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-319-12679-1_9 · Cited by 3
Molecular Pathways in Alzheimer’s Disease and Cognitive Function
Chen, X., Reichert, M. C., & Gan, L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802851-3.00005-x · Cited by 3
Morphometric analysis of thalamic volume in progressive supranuclear palsy: In vivo evidence of regionally specific bilateral thalamic atrophy
Power, B., Jakabek, D., Hunter‐Dickson, M., Wilkes, F., van Westen, D., Santillo, A. F., Walterfang, M., Velakoulis, D., Nilsson, C. F., & Looi, J. C. (2017) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2017.05.004 · Cited by 3
Pseudonystagmus in progressive supranuclear palsy
Ticku, H., Fotedar, N., Juncos, J. J., Factor, S. A., & Shaikh, A. G. (2022) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2022.120157 · Cited by 3
Comparison of Amyloid in Cerebrospinal Fluid, Brain Imaging, and Autopsy in a Case of Progressive Supranuclear Palsy
Kim, K. H., Seo, J. D., Kim, E. S., Kim, H.-S., Jeon, S., Pak, K., Lee, M. J., Lee, J., Lee, Y. M., Lee, K., et al. (2020) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000396 · Cited by 3
White Matter β-Amyloid Precursor Protein Immunoreactivity in Autopsied Subjects With and Without COVID-19Preprint
Beach, T. G., Deture, M. A., Walker, J. E., Arce, R. A., Glass, M. J., Sue, L. I., Intorcia, A. J., Nelson, C. M., Suszczewicz, K. E., Borja, C. I., et al. (2021) · medRxiv · doi:10.1101/2021.12.16.21266656 · Cited by 3
Self-citation
Progressive Supranuclear Palsy
Shen, K., Almarzouqi, S. J., & Lee, A. G. (2018) · Springer eBooks · doi:10.1007/978-3-540-69000-9_1302 · Cited by 3
Identifying Common Disease Trajectories of Progressive Supranuclear Palsy with Electronic Health Records
Fu, M., Sankararaman, S., Vossel, K. A., & Chang, T. S. (2025) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.70119 · Cited by 2
Magnetic Susceptibility and Area in the Subthalamic Nucleus Measured by QSM for Diagnosis of Progressive Supranuclear Palsy
Haji, S., Sako, W., Hanada, K., Matsubara, T., Osaki, Y., Matsumoto, Y., Harada, M., & Izumi, Y. (2025) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.70153 · Cited by 2
Progressive Supranuclear Palsy and Corticobasal Syndrome
McFarland, N. R. (2025) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/cont.0000000000001607 · Cited by 2
A Mathematical Model of Cellular Aggregation Predicts Patterns of Tau Accumulation in Neurodegenerative Disease
Huang, S., Quaegebeur, A., Pansuwan, T., Rittman, T., Wang, R., Knowles, T. P. J., Rowe, J. B., Klenerman, D., & Meisl, G. (2025) · Advanced Science · doi:10.1002/advs.202511297 · Cited by 4
Data-Driven differentiation of idiopathic Normal-Pressure hydrocephalus and progressive supranuclear palsy via automated volumetric analysis
Yun, S., Song, Y., Suh, C. H., Jung, W., Lee, S. H., Kim, S., Choi, K. S., Heo, H., Shim, W. H., Jo, S., et al. (2025) · Neuroradiology · doi:10.1007/s00234-025-03830-8 · Cited by 2
PET evaluation of cholinergic system differences in progressive supranuclear palsy and age-matched controls using [18F]VAT
Nai, Y., O’Donnell, J. L., Tanenbaum, A., Soda, A. K., Jiang, H., Moerlein, S. M., Norris, S. A., Perlmutter, J. S., & Tu, Z. (2025) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2025.109599 · Cited by 2
Untersuchung der Okulomotorik als differenzialdiagnostisches Instrument bei Parkinson-Syndromen
Pinkhardt, E. H., & Kassubek, J. (2011) · Nervenheilkunde · doi:10.1055/s-0038-1627799 · Cited by 2
Degeneration of the Brainstem
Bote, R. P., & Fernández-Gil, M. Á. (2013) · Seminars in Ultrasound CT and MRI · doi:10.1053/j.sult.2013.01.005 · Cited by 2
Corticobasal Degeneration
Niethammer, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-82367-2_32 · Cited by 2
Pathology vs pathogenesis: Rationale and pitfalls in the clinicopathology model of neurodegeneration
Donadio, V. A., Sturchio, A., Rizzo, G., Abu‐Rumeileh, S., Liguori, R., & Espay, A. J. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-85538-9.00001-8 · Cited by 2
Visual fixation suppression of caloric nystagmus in progressive supranuclear palsy – A comparison with Parkinson’s disease
Naito, R., Watanabe, Y. S., Naito, A., Sugasawa, K., Nakata, Y., Kamiyama, T., Okiyama, R., Yokochi, F., Isozaki, E., Yamasoba, T., et al. (2023) · Journal of Vestibular Research · doi:10.3233/ves-210147 · Cited by 2
Pathologically Confirmed Alzheimer's Disease Presenting as Clinical Parkinson's Disease, A Case Report
Mohammadzadeh, N., Wu, C., Donahue, J. E., & Friedman, J. H. (2024) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.14149 · Cited by 2
Deep Learning‐Based Brainstem Segmentation and Multi‐Class Classification for Parkinsonian Syndrome
Kim, S., Suh, P. S., Shim, W. H., Heo, H., Park, C., Hong, E., Kim, S., Lee, S. H., Lee, D., Jung, W., et al. (2025) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.70215 · Cited by 2
Dementia in Parkinson’s Disease and Atypical Parkinsonism
Stamelou, M., & Bhatia, K. P. (2014) · Springer eBooks · doi:10.1007/978-1-4471-6365-7_11 · Cited by 2
Atlas of Gross Neuropathology
Kurian, K. M., Moss, T. H., & Camelo-Piragua, S. I. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139680783 · Cited by 2
Pathologic Lesions in Alzheimer Disease and Other Neurodegenerative Diseases—Cellular and Molecular Components
Vinters, H. V., Tung, S., & Solis, O. E. (2011) · Springer eBooks · doi:10.1007/978-94-007-2774-8_2 · Cited by 2
Progressive Supranuclear Palsy and Related Parkinsonian Disorders
Brown, J. A., & Seeley, W. W. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800105-9.00018-4 · Cited by 2
Forensic Aspects of Adult and General Neuropathology
Leestma, J. (2008) · CRC Press eBooks · doi:10.1201/9781420008685.ch3 · Cited by 3
Improving parkinsonism diagnosis with machine learning
Abel, S., & Kolind, S. (2019) · The Lancet Digital Health · doi:10.1016/s2589-7500(19)30107-4 · Cited by 2
Neuropsychology of Movement Disorders and Motor Neuron Disease: Parkinson’s Disease, Progressive Supranuclear Palsy, Essential Tremor, Huntington’s Disease, and Amyotrophic Lateral Sclerosis
Tröster, A. I., Pulaski, S. J., & Woods, S. P. (2019) · Springer eBooks · doi:10.1007/978-3-030-14895-9_19 · Cited by 2
Neuropathology of Movement Disorders
Jellinger, K. A. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5316-3.00076-9 · Cited by 2
Novel Conformation-Dependent Tau Antibodies Are Modulated by Adjacent Phosphorylation Sites
Paterno, G., Torrellas, J., Bell, B. M., Gorion, K.-M. M., Quintin, S. S., Hery, G. P., Prokop, S., & Giasson, B. I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813676 · Cited by 2
Primary Progressive Apraxia of Speech Caused by TDP-43
Meade, G. F., Whitwell, J. L., Dickson, D. W., Duffy, J. R., Clark, H. M., Ahlskog, J. E., Machulda, M. M., Josephs, K. A., & Utianski, R. L. (2024) · Neurology Genetics · doi:10.1212/nxg.0000000000200134 · Cited by 2
Self-citation
Progressive Supranuclear Palsy
Morris, H. R. (2017) · Neurodegeneration · doi:10.1002/9781118661895.ch8 · Cited by 2
Slowing of Frontocentral Beta Oscillations in Atypical ParkinsonismPreprint
Krösche, M., Kannenberg, S., Butz, M., Hartmann, C. J., Florin, E., Schnitzler, A., & Hirschmann, J. V. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.19.488835 · Cited by 3
MAPT expression is mediated by long-range interactions with cis -regulatory elementsPreprint
Rogers, B. B., Anderson, A. G., Lauzon, S. N., Davis, M. N., Hauser, R. M., Roberts, S. C., Rodríguez-Nunez, I., Trausch‐Lowther, K., Barinaga, E. A., Taylor, J. W., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.07.531520 · Cited by 2
Long-standing preservation of levodopa response in progressive supranuclear palsy
Sano, T., Mizutani, M., Ishihara, T., Hara, N., Miyashita, A., Ikeuchi, T., Hasegawa, M., Takahashi, Y., & Takao, M. (2024) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2024.123203 · Cited by 1
Frontotemporal lobar degeneration changes neuronal beta-frequency dynamics during the mismatch negativity response
Perry, A., Hughes, L. E., Adams, N., Naessens, M., Kloosterman, N. A., Rouse, M. A., Murley, A. G., Street, D., Jones, P. S., & Rowe, J. B. (2024) · NeuroImage Clinical · doi:10.1016/j.nicl.2024.103671 · Cited by 1
Localized Iron Deposition and Shape Changes of Cerebellar Dentate in Progressive Supranuclear Palsy Clinical Variants
Wang, A. H., Youssef, H., Ali, F., Josephs, K. A., Whitwell, J. L., & Satoh, R. (2026) · Movement Disorders · doi:10.1002/mds.70204 · Cited by 1
Clinicopathological features of primary tauopathies: a brain bank series
Ryan, B., Marriott, L., Murray, H. C., Faull, R. L. M., Turner, C. P., & Curtis, M. A. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1768959 · Cited by 1
From Protein Tangles to Genetic Variants: The Central Role of Tau in Neurodegenerative Disease
Julia, H., & Wade‐Martins, R. (2011) · InTech eBooks · doi:10.5772/29839 · Cited by 1
Typical or atypical progressive supranuclear palsy: a comparative clinicopathologic study of three Chinese cases.
Zhu, M., Liu, J., Arzberger, T., Wang, L., & Wang, Z. (2015) · Europe PMC (PubMed Central) · Cited by 1
Progressive supranuclear palsy
Balekundri, A., Ahire, E. D., Surana, K. R., & Keservani, R. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95735-9.00022-x · Cited by 1
Progressive Supranuclear Palsy (PSP)
Frucht, S. J., & Termsarasab, P. (2024) · Springer eBooks · doi:10.1007/978-3-031-52573-5_4 · Cited by 1
Flattened red nucleus in progressive supranuclear palsy detected by quantitative susceptibility mapping
Kawabata, K., Banno, F., Mizutani, Y., Maeda, T., Nagao, R., Shima, S., Murayama, K., Ohno, Y., Maeda, T., Sasaki, M., et al. (2024) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2024.107251 · Cited by 1
Deep brain stimulation in progressive supranuclear palsy: a dead-end story? A narrative review
Bellini, G., Rauso, G. D., Fontanelli, L., Benevento, E., Becattini, L., Frosini, D., Ceravolo, R., & Prete, E. D. (2025) · Journal of Neural Transmission · doi:10.1007/s00702-025-02904-4 · Cited by 1
The potential of proteomics for in-depth molecular investigations of progressive supranuclear palsy
Romero-Murillo, S., Lee, S., Fernández‐Irigoyen, J., Martínez-Valbuena, I., & Santamaría, E. (2025) · Expert Review of Proteomics · doi:10.1080/14789450.2025.2519466 · Cited by 1
Morphometric Analyses in Movement Disorders
Draganski, B., & Accolla, E. A. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-471-5_2 · Cited by 1
PET and SPECT Imaging in Atypical Parkinsonian Syndromes
Niethammer, M., Choi, Y. Y., Tang, C. C., & Eidelberg, D. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_26 · Cited by 1
Modeling Taupathies in Zebrafish (Danio rerio)
Kotova, M. M., Kolesnikova, T. O., & Kalueff, A. V. (2023) · Российский физиологический журнал им И М Сеченова · doi:10.31857/s0869813923110067 · Cited by 1
Neurodegenerative disease
Kurian, K. M., Moss, T. H., & Camelo-Piragua, S. I. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139680783.010 · Cited by 1
Innovative MRT-Kontraste zur in-vivo-Differenzierung von Patienten mit typischem idiopathischen Parkinson und atypischen Parkinsonsyndromen
Pantel, P. M. (2013) · doi:10.53846/goediss-4203
Corticobasal degeneration and progressive supranuclear palsy
Lee, S. E., & Miller, B. L. (2016) · Wiley eBooks · doi:10.1002/9781118797662.ch7 · Cited by 1
CXCR4 involvement in neurodegenerative diseasesPreprint
Bonham, L. W., Karch, C. M. M., Fan, C. C., Tan, C. H., Geier, E. G., Wang, Y., Wen, N., Broce, I., Li, Y., Barkovich, M. J., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/181693 · Cited by 1
The role of tau and neuroinflammation in Progressive Supranuclear Palsy and Alzheimer's Disease
Rodríguez, P. V. (2019) · Apollo (University of Cambridge) · doi:10.17863/cam.45106 · Cited by 1
A Systematic Review and Meta-Analysis of Deep Brain Stimulation for Progressive Supranuclear PalsyPreprint
Wen, Y., Jiao, B., Zhou, Y., & Shen, L. H. (2020) · Research Square · doi:10.21203/rs.3.rs-122655/v1 · Cited by 1
Tau accumulation patterns in PSP constrain mechanisms and quantify cell-to-cell and cell-autonomous aggregation ratesPreprint
Huang, S., Quaegebeur, A., Pansuwan, T., Rittman, T., Wang, R., Knowles, T. P. J., Rowe, J. B., Klenerman, D., & Meisl, G. (2024) · medRxiv · doi:10.1101/2024.12.14.24318991 · Cited by 1
Schmerzwahrnehmung und Schmerzempfindung bei Progressiver Supranukleärer Blickparese (PSP)
Dohmann, H. (2013) · open_UMR Marburg DSpace 10.0 (Philipps-Universität Marburg) · doi:10.17192/z2013.0132
Diagnosis and Management of Progressive Supranuclear Palsy
Gupta, A., & Fox, S. H. (2009)
Tau Pathology: A Selected View on the Current Status
Gozes, I. (2012) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-94-007-5866-7_5
Tauopathies
Kovács, G. G. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107588660.008
Falling before forgetting
Jelić, V., Nennesmo, I., Pålhagen, S.-E., & Winblad, B. G. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511997433.036
The cognitive neurology of corticobasal degeneration and progressive supranuclear palsy
Fredericks, C. A., & Lee, S. E. (2016) · Cambridge University Press eBooks · doi:10.1017/9781139924771.015
Anatomical and quantitative structural MRI studies in Parkinsonian disorders
Al-Helli, O. (2017) · UCL Discovery (University College London)
Implication of Alpha-synuclein Transcriptional Regulation and Mutagenesis in the Pathogenesis of Sporadic Parkinson's Disease
Basu, S. (2017) · Journal of International Crisis and Risk Communication Research
Functional Anatomy of the Cerebellum and Brainstem
Agarwal, N. (2017) · Springer eBooks · doi:10.1007/978-3-319-57427-1_11
Movement Disorders
Fekete, R., Jankovic, J. J., Shill, H. A., Evidente, V. G. H., & Gwinn, K. A. (2014) · Wiley eBooks · doi:10.1002/9781118730676.ch12
Stimmstörungen – ein Fokus der Klinischen Sprechwissenschaft : Aktuelle Beiträge aus Wissenschaft, Forschung und Praxis
(Saale), D. B. K. S. 2. H., Voigt-Zimmermann, S., Kurtenbach, S., Finkbeiner, G., Bergt, A., Mainka, W., & Timme, F. &. (2016) · Frank & Timme eBooks · doi:10.26530/20.500.12657/42799
Imaging of FTLD-tau Using [18F]AV-1451
Burke, C. (2017) · TSpace (University of Toronto)
Multimodality Anatomic and Molecular Imaging of Parkinson Disease and Atypical Parkinson Syndromes with MRI, Iodine 123 N-ω-Fluoropropyl-2β-Carbomethoxy-3β-(4-Iodophenyl) Nortropane SPECT (Dopamine Transporter SPECT), Iodine 123 Metaiodobenzylguanidine Cardiac Scintigraphy, and [18F] FDG-PET
Duignan, J. A., Haughey, A. M., Hughes, N., Kelly, B. S., Lucey, J. A., McGuigan, C., Kinsella, J. A., & Killeen, R. P. (2021) · Neurographics · doi:10.3174/ng.2000070
Forensic Aspects of Adult and General Neuropathology
Leestma, J. E. (2014) · CRC Press eBooks · doi:10.1201/b16882-4
Progressive Supranuclear Palsy
Shen, K., Almarzouqi, S. J., & Lee, A. G. (2015) · Springer eBooks · doi:10.1007/978-3-642-35951-4_1302-1
Parkinsonism: Genetics
Gubitz, A. K., Corriveau, R. A., & Gwinn, K. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374105-9.00541-4
Annonacin in Asimina triloba fruit : implications for neurotoxicity.
Potts, L. (2011) · doi:10.18297/etd/1145
The Spectrum of Tau Pathology in Human Prion Disease
Kovács, G. G., & Budka, H. (2023) · Springer eBooks · doi:10.1007/978-3-031-20565-1_21
Differentiating Progressive Supranuclear Palsy from Other Movement Disorders Using Transcranial Sonography: A Systematic Review and Meta-AnalysisPreprint
Wen, Y., Zhou, H., Xia, M., Liu, Q., Quan, H., & Fang, L. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4462192
Rhombomere 10 r10
Schröder, H., de Vos, R. A. I., Huggenberger, S., Müller-Thomsen, L., Rozemüller, A. J. M., Hedayat, F., & Moser, N. (2023) · Springer eBooks · doi:10.1007/978-3-030-89980-6_4
Modeling Tauopathies in Zebrafish (Danio rerio)
Kotova, M. M., Kolesnikova, T. O., & Kalueff, A. V. (2023) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093023060133
Loss of Mickey Mouse Ears’ Sign in Progressive Supranuclear Palsy
Chow, T.-K., & Ma, K. M. (2024) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000005229
Boundary-based registration improves sensitivity for detecting hypoperfusion in sporadic frontotemporal lobar degeneration
Mihailescu, S., Hlava, Q., Cook, P. A., Mandelli, M. L., Lee, S. E., Boeve, B. F., Dickerson, B. C., Gorno‐Tempini, M. L., Rogalski, E. J., Grossman, M., et al. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1452944
Parkinson disease and Parkinsonism
Hayes, M. T. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-12642-0.00014-1
Neuropathological Overview of Neurodegenerative Disorders
Wolters, E. C. (2025) · Cambridge University Press eBooks · doi:10.1017/9781108989855.006
Confocal Imaging of Cells in Thick Rat Cerebrum Using Hoechst Stain
Sharma, A., Natanasabapathi, G., & Agrawal, D. K. (2025) · Indian Journal of Neurotrauma · doi:10.1055/s-0045-1805092
Comparing and combining TSPO-PET tracers in tauopathiesPreprint
Crook, H., Franzmeier, N., Rahmouni, N., Gnörich, J. S., Fryer, T. D., Hong, Y. T., Roemer, S. N., Palleis, C., Strauss, A., Jones, P. S., et al. (2025) · medRxiv · doi:10.1101/2025.07.23.25332044
Diagnostic utility of tectal plate measures in clinical variants of progressive supranuclear palsy
Singh, N. A., Blakey, M., Satoh, R., Ali, F., Pham, N. T. T., Amrami, A., Stephens, Y. C., Dickson, D. W., Josephs, K. A., & Whitwell, J. L. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13256-0
Self-citation
Tauopathy strains differentially replicate in vitro in the presence of mutant tau monomer
Brown, C. K., Frost, M. P., Holec, S. A. M., Seeley, W. W., Grinberg, L. T., Olson, S. H., & Woerman, A. L. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107052
Nanoscopic tau aggregates in Parkinson’s disease
Layburn, F. E., Böken, D., Zhang, Y., Halliday, K., Rodgers, D., Kedia, S., Nolan, G., Kahanawita, L., Bd, P., Quaegebeur, A., et al. (2026) · npj Parkinson s Disease · doi:10.1038/s41531-026-01489-3
The Cognitive Neurology of Corticobasal Degeneration and Progressive Supranuclear Palsy
Lee, S. E., & Fredericks, C. A. (2025) · Cambridge University Press eBooks · doi:10.1017/9781108985055.013
Woman with gait impairment and difficulty reading
Ferrara, J. M., & Litvan, I. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511997433.033
Multiple pathologies in dementia : correlations with clinical diagnoses
Echávarri, C. (2012) · Research Publications (Maastricht University) · doi:10.26481/dis.20121018ce
I deficit cognitivi nelle sindromi extrapiramidali con demenza
Perri, R., & Carlesimo, G. A. (2009) · Springer eBooks · doi:10.1007/978-88-470-1490-9_4
Additional file 1 of Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsy
Strickland, S. L., Morel, H., Prusinski, C., Allen, M., Patel, T. A., Carrasquillo, M. M., Conway, O. J., Lincoln, S., Reddy, J. S., Nguyen, T., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13141811
Self-citation
Additional file 1 of Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degeneration
Koga, S., Metrick, M. A., Golbe, L. I., Santambrogio, A., Kim, M., Soto‐Beasley, A. I., Walton, R. L., Baker, M., De Castro, C. F., Deture, M. A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26593406
Self-citation
Astrocytic Receptor Systems of the Basal Ganglia
Tushevski, A., Happe, L., Stocco, E., De, R., Macchi, V., Porzionato, A., & Emmi, A. (2025) · Receptors · doi:10.3390/receptors5010002
The brainstem in neurodegenerative diseases
Grinberg, L. T. (2026) · Handbook of clinical neurology · doi:10.1016/b978-0-443-15736-3.00017-2
Déterminants structuraux d’agrégats de Tau distincts : vers de nouveaux outils moléculaires pour discriminer les tauopathies
Caroux, E. (2019) · theses.fr (ABES) · doi:10.70675/35d706bfz0d1bz440ezac4bz7fd4138464f8
Language impairments in neurodegenerative diseases : function, dysfunction and modulation with transcranial stimulation
Sanches, M. C. P. (2019) · theses.fr (ABES) · doi:10.70675/23d3688fza2a5z4b5czace8z77e89e074aaf
Apport de l'IRM multimodale pour le diagnostic différentiel des syndromes parkinsoniens
Chougar, L. (2022) · doi:10.70675/eebdb441z4314z48f5zab1aze3d95f0d4e54
Risk genes in progressive supranuclear palsy (PSP) affect integrity and function of microtubules
Donlon, T. A., & Müller, U. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1769377
Altered astrocyte–neuron crosstalk in progressive supranuclear palsy: integrated evidence from proteomics and magnetic resonance spectroscopy
Ono, M., Kumagai, Y., Hirata, K., Maeda, Y., Abe, Y., Endo, H., Shimizu, H., Kakita, A., Uchida, Y., & Takado, Y. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-03020-7
Spatiotemporal Tau Accumulation and Its Clinical Impact on PSP: Longitudinal Florzolotau (18F) PETPreprint
Chishiki, Y., Tagai, K., Kataoka, Y., Goto, R., Osawa, K., Oyama, A., Matsumoto, H., Ichihashi, M., Momota, Y., Kamada, T., et al. (2026) · medRxiv · doi:10.64898/2026.04.26.26350467
A Systematic Review on Disease‐Modifying Therapies in Parkinsonian Disorders
Eijsvogel, P. P. N. M., Smits, L. M. G., Kremer, P. H. C., & Groeneveld, G. J. (2026) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.70315 · Cited by 1

Authors: Dickson, D. W., Rademakers, R., & Hutton, M. L.
Affiliations: Mayo Clinic in Florida (US)
ORCID: Dickson, Dennis W.
Rademakers, Rosa
Venue: Brain Pathology
Publisher: Wiley
Published: 2007-01
Volume: 17
Issue: 1
Pages: 74-82
ISSN: 1015-6305 (ISSN-L)
1750-3639
DOI: 10.1111/j.1750-3639.2007.00054.x
PMC: PMC8095545
OpenAlex: W2014875179
Cited by: 314
References: 99
Citations by year: 2026: 20 · 2025: 24 · 2024: 25 · 2023: 25 · 2022: 15 · 2021: 17 · 2020: 11 · 2019: 18 · 2018: 7 · 2017: 25 · 2016: 19 · 2015: 11 · 2014: 17 · 2013: 14 · 2012: 10
FWCI: 1.58
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 56 d)
Locations: Brain Pathology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute on Aging (R01AG015866, P01AG014449, P01AG003949, P50AG025711, P01AG017216, P50AG016574)
National Institute of Neurological Disorders and Stroke (P01NS040256, P50NS040256)
National Institute of Environmental Health Sciences (R01ES013941, R01-ES02941)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords: progressive supranuclear palsy, tauopathy, tau pathology, MAPT gene, tau isoforms, atypical parkinsonism, subthalamic nucleus, midbrain tectum, superior cerebellar peduncle, nigrostriatal degeneration, neurofibrillary tangles, gliosis, brainstem atrophy, differential diagnosis, diagnostic biomarkers, neuroimaging
MeSH terms: Humans, Supranuclear Palsy, Progressive, tau Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Progressive Supranuclear Palsy: Pathology and Genetics

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks